What is LIS Technologies?
LIS Technologies Inc. (LIST) operates as a premier developer of advanced laser-based isotope separation solutions. Headquartered in the United States, the company utilizes patented infrared laser technology to selectively excite specific isotopes, facilitating their separation from complex mixtures with unprecedented precision. This proprietary methodology provides a critical advantage over traditional, energy-intensive enrichment processes. As the only USA-origin entity specializing in this specific laser-based uranium enrichment pathway, LIS Technologies occupies a unique niche in the global energy and materials science landscape. Its technology is designed to enhance efficiency, reduce operational footprints, and provide a more sustainable approach to isotope production compared to conventional industrial standards.
How much funding has LIS Technologies raised?
LIS Technologies has raised a total of $30.2M across 3 funding rounds:
Angel/Seed
$11.3M
Other Financing Round
$11.9M
Stock/Share Issuance
$7M
Angel/Seed (2024): $11.3M with participation from 28 Ventures Revenue Roll Spv
Other Financing Round (2025): $11.9M led by 28 South Ventures
Stock/Share Issuance (2026): $7M, investors not publicly disclosed
Key Investors in LIS Technologies
28 Ventures Revenue Roll Spv
A venture capital and private equity firm based in New York that focuses on early-stage capital deployment and revenue-generating ventures.
28 South Ventures
A diversified investment entity with a strong operational background in retail and distribution, providing strategic support to emerging technology firms.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for LIS Technologies?
With the successful closure of its most recent financing round, LIS Technologies is poised to transition from research and development into broader industrial application. The strategic focus will likely center on scaling its proprietary laser infrastructure to meet the growing demand for high-purity isotopes in both energy and medical sectors. By optimizing its patented processes, the firm aims to disrupt the status quo of the enrichment industry, potentially setting new benchmarks for cost-effectiveness and environmental sustainability. Future milestones will likely involve the expansion of manufacturing capabilities and the pursuit of regulatory approvals necessary for large-scale commercial deployment, further cementing its role as a pivotal player in advanced nuclear technology.
See full LIS Technologies company page
